Dizhe Pharmaceutical (688192.SH) Hong Kong IPO Prospectus Expires After Six-Month Validity Period

GS1.16%
According to Zhitong Finance, Dizhe Pharmaceutical (江苏迪哲医药股份有限公司)'s Hong Kong IPO prospectus, initially submitted on January 23, 2026, expired on July 23, 2026, as it exceeded the six-month validity window. Goldman Sachs and China International Capital Corporation served as joint sponsors for the proposed offering.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments